Search Browse Earnings

Aldeyra Therapeutics, Inc. — SlamSEC

Aldeyra Therapeutics, Inc.

Nasdaq:ALDX

Pharmaceutical Preparations·LEXINGTON, MA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

—

Adj. EBITDA

-$59.9M

FY 2025

Net Income

-$55.9M

FY 2025

EPS (Diluted)

-$0.94

FY 2025

Stock Price

$4.94

-1.4%

2026-03-11

52W Range

$1.14 – $7.20

P/E Ratio

-5.3x

Market Cap

$297.3M

Cash

$54.5M

FY 2025

Total Debt

$15.0M

FY 2025

Net Cash

$39.5M

FY 2025

Enterprise Value

$257.8M

Debt / EBITDA

0.7x

FY 2025

EV / EBITDA

-4.3x

Employees

—